LinkedIn Profile

Access Delinia historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal GICS Sector GICS Industry
private:deliniabio 10846555 Nov 18th, 2019 12:00AM Delinia 164 0.00 Open Biotechnology Nov 18th, 2019 04:07PM Nov 18th, 2019 04:07PM Delinia is a biotechnology company developing novel therapeutics for the treatment of serious autoimmune diseases. Delinia's lead program is a molecule that potentiates and expands Regulatory T Cells (Tregs), powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the pathophysiology of cancer and autoimmune disease. Open Open 953 Indiana Street San Francisco California (CA) US 94107
private:deliniabio 10846555 Nov 17th, 2019 12:00AM Delinia 164 0.00 Open Biotechnology Nov 17th, 2019 04:33PM Nov 17th, 2019 04:33PM Delinia is a biotechnology company developing novel therapeutics for the treatment of serious autoimmune diseases. Delinia's lead program is a molecule that potentiates and expands Regulatory T Cells (Tregs), powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the pathophysiology of cancer and autoimmune disease. Open Open 953 Indiana Street San Francisco California (CA) US 94107
private:deliniabio 10846555 Nov 16th, 2019 12:00AM Delinia 164 0.00 Open Biotechnology Nov 16th, 2019 04:27PM Nov 16th, 2019 04:27PM Delinia is a biotechnology company developing novel therapeutics for the treatment of serious autoimmune diseases. Delinia's lead program is a molecule that potentiates and expands Regulatory T Cells (Tregs), powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the pathophysiology of cancer and autoimmune disease. Open Open 953 Indiana Street San Francisco California (CA) US 94107
private:deliniabio 10846555 Nov 15th, 2019 12:00AM Delinia 164 0.00 Open Biotechnology Nov 15th, 2019 01:05PM Nov 15th, 2019 01:05PM Delinia is a biotechnology company developing novel therapeutics for the treatment of serious autoimmune diseases. Delinia's lead program is a molecule that potentiates and expands Regulatory T Cells (Tregs), powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the pathophysiology of cancer and autoimmune disease. Open Open 953 Indiana Street San Francisco California (CA) US 94107
private:deliniabio 10846555 Nov 13th, 2019 12:00AM Delinia 164 0.00 Open Biotechnology Nov 13th, 2019 01:29PM Nov 13th, 2019 01:29PM Delinia is a biotechnology company developing novel therapeutics for the treatment of serious autoimmune diseases. Delinia's lead program is a molecule that potentiates and expands Regulatory T Cells (Tregs), powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the pathophysiology of cancer and autoimmune disease. Open Open 953 Indiana Street San Francisco California (CA) US 94107
private:deliniabio 10846555 Nov 12th, 2019 12:00AM Delinia 164 0.00 Open Biotechnology Nov 12th, 2019 03:10PM Nov 12th, 2019 03:10PM Delinia is a biotechnology company developing novel therapeutics for the treatment of serious autoimmune diseases. Delinia's lead program is a molecule that potentiates and expands Regulatory T Cells (Tregs), powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the pathophysiology of cancer and autoimmune disease. Open Open 953 Indiana Street San Francisco California (CA) US 94107
private:deliniabio 10846555 Nov 11th, 2019 12:00AM Delinia 164 0.00 Open Biotechnology Nov 11th, 2019 03:08PM Nov 11th, 2019 03:08PM Delinia is a biotechnology company developing novel therapeutics for the treatment of serious autoimmune diseases. Delinia's lead program is a molecule that potentiates and expands Regulatory T Cells (Tregs), powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the pathophysiology of cancer and autoimmune disease. Open Open 953 Indiana Street San Francisco California (CA) US 94107
private:deliniabio 10846555 Nov 10th, 2019 12:00AM Delinia 164 0.00 Open Biotechnology Nov 10th, 2019 06:15PM Nov 10th, 2019 06:15PM Delinia is a biotechnology company developing novel therapeutics for the treatment of serious autoimmune diseases. Delinia's lead program is a molecule that potentiates and expands Regulatory T Cells (Tregs), powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the pathophysiology of cancer and autoimmune disease. Open Open 953 Indiana Street San Francisco California (CA) US 94107
private:deliniabio 10846555 Nov 9th, 2019 12:00AM Delinia 164 0.00 Open Biotechnology Nov 9th, 2019 05:42PM Nov 9th, 2019 05:42PM Delinia is a biotechnology company developing novel therapeutics for the treatment of serious autoimmune diseases. Delinia's lead program is a molecule that potentiates and expands Regulatory T Cells (Tregs), powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the pathophysiology of cancer and autoimmune disease. Open Open 953 Indiana Street San Francisco California (CA) US 94107
private:deliniabio 10846555 Nov 8th, 2019 12:00AM Delinia 164 0.00 Open Biotechnology Nov 8th, 2019 02:53PM Nov 8th, 2019 02:53PM Delinia is a biotechnology company developing novel therapeutics for the treatment of serious autoimmune diseases. Delinia's lead program is a molecule that potentiates and expands Regulatory T Cells (Tregs), powerful immune cells that are critical to maintaining self-tolerance and immune system homeostasis. Tregs are critically important immune regulatory cells in the pathophysiology of cancer and autoimmune disease. Open Open 953 Indiana Street San Francisco California (CA) US 94107

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.